HomeALPMF • OTCMKTS
add
Astellas Pharma Inc
Previous close
$12.00
Year range
$9.13 - $12.86
Market cap
3.19T JPY
Avg Volume
1.31K
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
In the news
Financials
Income Statement
Revenue
Net income
| (JPY) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 473.12B | 26.17% |
Operating expense | 328.67B | 25.93% |
Net income | 37.60B | 13.50% |
Net profit margin | 7.95 | -9.97% |
Earnings per share | — | — |
EBITDA | 103.59B | 51.67% |
Effective tax rate | 25.53% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 302.93B | -46.05% |
Total assets | 3.74T | 33.51% |
Total liabilities | 2.06T | 68.84% |
Total equity | 1.68T | — |
Shares outstanding | 1.79B | — |
Price to book | 0.01 | — |
Return on assets | 3.65% | — |
Return on capital | 5.14% | — |
Cash Flow
Net change in cash
| (JPY) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 37.60B | 13.50% |
Cash from operations | 12.60B | 3.30% |
Cash from investing | -39.35B | -219.91% |
Cash from financing | -11.92B | -107.22% |
Net change in cash | -32.76B | -117.74% |
Free cash flow | -10.77B | -238.22% |
About
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Founded
Apr 1, 2005
Headquarters
Website
Employees
14,754
